https://live-ray-therapeutics-inc.pantheonsite.io/hello-world/2025-05-04T17:57:32-07:00https://live-ray-therapeutics-inc.pantheonsite.io/ray-therapeutics-and-forge-biologics-announce-viral-vector-contract-development-and-cgmp-manufacturing-partnership/2025-05-04T17:57:27-07:00https://live-ray-therapeutics-inc.pantheonsite.io/ray-therapeutics-receives-4m-in-funding-from-the-california-institute-for-regenerative-medicine-cirm/2025-05-04T18:02:07-07:00https://live-ray-therapeutics-inc.pantheonsite.io/ray-therapeutics-appoints-dr-peter-francis-as-chief-scientific-medical-officer-and-jenny-holt-as-svp-program-portfolio-management/2025-05-04T18:03:55-07:00https://live-ray-therapeutics-inc.pantheonsite.io/ray-therapeutics-and-forge-biologics-expand-their-viral-vector-cgmp-partnership-to-encompass-plasmid-dna-manufacturing/2025-05-04T18:06:16-07:00https://live-ray-therapeutics-inc.pantheonsite.io/ray-therapeutics-to-present-at-upcoming-scientific-conferences/2025-05-04T18:07:42-07:00https://live-ray-therapeutics-inc.pantheonsite.io/ray-therapeutics-closes-oversubscribed-100m-series-a-financing-to-advance-optogenetic-gene-therapies-for-blinding-diseases/2025-05-04T18:09:42-07:00https://live-ray-therapeutics-inc.pantheonsite.io/ray-therapeutics-appoints-christopher-whitmore-as-chief-financial-officer/2025-05-04T18:11:04-07:00https://live-ray-therapeutics-inc.pantheonsite.io/ray-therapeutics-awarded-8m-cirm-grant-to-advance-rtx-015-gene-therapy-for-retinitis-pigmentosa/2025-05-04T18:12:42-07:00https://live-ray-therapeutics-inc.pantheonsite.io/ray-therapeutics-appoints-scott-braunstein-m-d-as-chairman-of-the-board-of-directors/2026-01-08T11:31:40-08:00https://live-ray-therapeutics-inc.pantheonsite.io/ray-therapeutics-appoints-michael-murtagh-as-chief-regulatory-officer/2026-02-17T09:17:13-08:00https://live-ray-therapeutics-inc.pantheonsite.io/ray-therapeutics-receives-fda-regenerative-medicine-advanced-therapy-rmat-designation-for-rtx-015-in-retinitis-pigmentosa/2026-04-01T18:09:27-07:00https://live-ray-therapeutics-inc.pantheonsite.io/ray-therapeutics-announces-upsized-and-oversubscribed-125-million-series-b-financing-for-vision-restoration-treatments/2026-04-30T10:04:54-07:00https://live-ray-therapeutics-inc.pantheonsite.io/ray-therapeutics-granted-priority-medicines-prime-designation-from-the-european-medicines-agency-for-rtx-015-in-retinitis-pigmentosa/2026-04-30T10:07:32-07:00https://live-ray-therapeutics-inc.pantheonsite.io/ray-therapeutics-expands-board-expertise-with-appointment-of-vikas-sinha-mba-as-director-and-chair-of-the-audit-committee/2026-05-28T20:07:44-07:00